Knockdown of STAT3 by shRNA inhibits the growth of CAOV3 ovarian cancer cell line in vitro and in vivo

Acta Biochimica et Biophysica Sinica

Volumn 40, Issue 6, 2008, Pages 519-525

  Huang, Feng ^a   Tong, Xiaoyun ^b   Fu, Liangqing ^c   Zhang, Ronghua ^a  

^a JINAN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c Beijing 307 Hospital   (China)

Author keywords

Apoptosis; CAOV3; Cell proliferation; siRNA; STAT3

Indexed keywords

STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

ANIMAL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE SILENCING; GENE THERAPY; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; MOUSE; NUDE MOUSE; OVARY TUMOR; PATHOLOGY; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE SILENCING; GENE THERAPY; HUMANS; MALE; MICE; MICE, NUDE; OVARIAN NEOPLASMS; STAT3 TRANSCRIPTION FACTOR; TREATMENT OUTCOME;

MUS MUSCULUS;

EID: 45349104588     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2008.00424.x     Document Type: Article

References (15)

1. Vernooij F, Heintz P, Witteveen E, van der Graaf Y. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol 2007, 105 : 801 812.
2. Burke WM, Jin X, Lin HJ, Huang M, Liu R, Reynolds RK, Lin J et al. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene 2001, 20 : 7925 7934.
3. Silver DL, Naora H, Liu J, Cheng W, Montell DJ. Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res 2004, 64 : 3550 3558.
4. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000, 19 : 2474 2488.
5. Nefedova Y, Gabrilovich DI. Targeting of Jak/STAT pathway in antigen presenting cells in cancer. Curr Cancer Drug Targets 2007, 7 : 71 77.
6. Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 2002, 99 : 6047 6052.
7. Germain D, Frank DA. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin Cancer Res 2007, 13 : 5665 5669.
8. Zhang X, Darnell JE Jr. Functional importance of Stat3 tetramerization in activation of the α 2-macroglobulin gene. J Biol Chem 2001, 276 : 33576 33581.
9. Germain D, Frank DA. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin Cancer Res 2007, 13 : 5665 5669.
10. Deng J, Grande F, Neamati N. Small molecule inhibitors of Stat3 signaling pathway. Curr Cancer Drug Targets 2007, 7 : 91 107.
11. Kim J, Kim H, Lee Y, Yang K, Byun S, Han K. A simple and economical short-oligonucleotide-based approach to shRNA generation. J Biochem Mol Biol 2006, 39 : 329 334.
12. Amarzguioui M, Rossi JJ, Kim D. Approaches for chemically synthesized siRNA and vector-mediated RNAi. FEBS Lett 2005, 579 : 5974 5981.
13. Mäkinen PI, Koponen JK, Kärkkäinen AM, Malm TM, Pulkkinen KH, Koistinaho J, Turunen MP et al. Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain. J Gene Med 2006, 8 : 433 441.
14. Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, Jing N et al. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides. Int J Oncol 2007, 31 : 129 136.
15. Shah NG, Trivedi TI, Tankshali RA, Goswami JA, Shah JS, Jetly DH, Kobawala TP et al. Molecular alterations in oral carcinogenesis: significant risk predictors in malignant transformation and tumor progression. Int J Biol Markers 2007, 22 : 132 143.